Hey rolly777, Just remember one thing. It's irrelevant what the Share price is trading at now, in deciding market cap- (price x number of shares). That's based off a pre revenue position, with proof of concept still being developed with all of the studies. If you have a look at the SP in 2021 based purely on FOMO, that $3.5B market cap at the time would still be spare change for BP should any of our three active studies, become a standard of care for any cancers. Even with the bile duct area, once used in areas with no answer to failings, such as this area- Oncologist's are able to use our product as an alternative SOC for other cancers.
Not a lot different to real estate. It's only worth what someone's willing to pay for it ! You get approval for a new SOC cancer product, on the back of irreputable data over years- watch BP lining up. Forget $3.5b they'll pay 5-10x that with their spare change.
Forget 3.9c even 15c by years end would be a joke for mine. It's hard to value at present, but I think it's worth more than that now, before all of the data and approvals land over coming months. !
-GO IMU!
Not Financial Advice - Opinions Only - DYOR!
IMU Price at posting:
4.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)